@article { author = {EMAN MAHMOUD FOUDA, M.D., MAHMOUD MOHAMED FOUAD, M.B.B.CH.; and HEBA ALLAH AHMED ALI, M.D., EMAN ABDEL-MONIEM EL-GOHARY, M.D.;}, title = {Predictive Value of Serum Copeptin as a Severity Marker of Community-Acquired Pneumonia in Pediatrics}, journal = {The Medical Journal of Cairo University}, volume = {90}, number = {6}, pages = {755-769}, year = {2022}, publisher = {The Clinical Society of Cairo University}, issn = {0045-3803}, eissn = {2536-9806}, doi = {10.21608/mjcu.2022.253170}, abstract = {AbstractBackground: Community-acquired pneumonia is the most severe form of acute respiratory infections.Aim of Study: This study aimed to assess the level of copeptin in community- acquired pneumonia in children.Patients and Methods: A cross- sectional study was conducted on 40 children with community acquired pneumoniaand another 30 healthy children as controls. Imaging techniques as X-ray, and computed topography were used toassess the diagnosis of pneumonia.Results: Blood levels of copeptin in children with pneumonia with a median of 55 pmol/L were much higher thancopeptin levels in controls groups (p-value <0.001).Pneumonia complications were reported in 15 (50.0%) Conclusion: Serum blood levels of copeptin might beused as a diagnostic measure for community- acquired pneumonia.}, keywords = {Community-acquired pneumonia,CAP,Copeptin,Procalcitonin}, url = {https://mjcu.journals.ekb.eg/article_253170.html}, eprint = {https://mjcu.journals.ekb.eg/article_253170_2afdc231dc99739b06cb87eb937bda3d.pdf} }